Related references
Note: Only part of the references are listed.F2R Polymorphisms and Clopidogrel Efficacy and Safety in Patients With Minor Stroke or TIA
Yuesong Pan et al.
NEUROLOGY (2021)
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
Yongjun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The Effect of Ticagrelor on Platelet Reactivity in Patients with Clopidogrel Resistance Undergoing Neuroendovascular Procedures
Adnan Iqbal Qureshi et al.
JOURNAL OF NEUROIMAGING (2020)
2018 ESC/EACTS Guidelines on myocardial revascularization
Franz-Josef Neumann et al.
EUROPEAN HEART JOURNAL (2019)
Periprocedural Neuroendovascular Antiplatelet Strategies for Thrombosis Prevention in Clopidogrel-Hyporesponsive Patients
Megan E. Barra et al.
PHARMACOTHERAPY (2019)
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
Yilong Wang et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials
Yuesong Pan et al.
JAMA NEUROLOGY (2019)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2019)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli et al.
EUROPEAN HEART JOURNAL (2018)
Management of antiplatelet therapy in patients undergoing neuroendovascular procedures
Keri S. Kim et al.
JOURNAL OF NEUROSURGERY (2018)
Ticagrelor for stroke prevention in patients with vascular risk factors: A systematic review and meta-analysis
Konark Malhotra et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
Qiukui Hao et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
A Case Series of 18 Patients Receiving Ticagrelor After Carotid Stenting
Elizabeth M. Olafson et al.
JOURNAL OF PHARMACY PRACTICE (2018)
Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack A Systematic Review and Meta-Analysis
Yuesong Pan et al.
CIRCULATION (2017)
Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis)
Colin P. Derdeyn et al.
STROKE (2017)
Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis
P. Gao et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack
Yilong Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Heidelberg Bleeding Classification Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy
Ruediger von Kummer et al.
STROKE (2015)
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial
Colin P. Derdeyn et al.
LANCET (2014)
Antiplatelet resistance in stroke
Mehmet Akif Topcuoglu et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
Simplified Modified Rankin Scale Questionnaire Reproducibility Over the Telephone and Validation With Quality of Life
Askiel Bruno et al.
STROKE (2011)
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies The RESPOND Study
Paul A. Gurbel et al.
CIRCULATION (2010)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Inhibition of platelet aggregation by AZD6140, A reversible oral P2Y12 receptor antagonist, compared with clopidogral in patients with acute coronary syndrome
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Share Paper
